CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Assets
Cash and due from banks	$ 481,414	$ 205,156
Interest bearing deposits with banks	906,898	1,844,764
Investment securities:
Equity securities	41,716	36,473
Trading debt securities	0	38,130
Available for sale debt securities	1,382,551	1,128,809
Held to maturity debt securities (net of allowance for credit losses of $1,508 at June 30, 2022 and $1,165 at December 31, 2021)	3,718,469	2,667,532
Total investment securities	5,142,736	3,870,944
Loans held for sale, at fair value	18,348	139,516
Loans	43,560,777	34,153,657
Less: Allowance for loan losses	(468,819)	(359,202)
Net loans	43,091,958	33,794,455
Premises and equipment, net	360,819	326,306
Lease right of use assets	315,820	259,117
Bank owned life insurance	714,762	566,770
Accrued interest receivable	134,682	96,882
Goodwill	1,871,505	1,459,008
Other intangible assets, net	218,642	70,386
Other assets	1,181,223	813,139
Total Assets	54,438,807	43,446,443
Deposits:
Non-interest bearing	16,139,559	11,675,748
Interest bearing:
Savings, NOW and money market	23,547,951	20,269,620
Time	4,193,541	3,687,044
Total deposits	43,881,051	35,632,412
Short-term borrowings	1,522,804	655,726
Long-term borrowings	1,403,805	1,423,676
Junior subordinated debentures issued to capital trusts	56,587	56,413
Lease liabilities	368,920	283,106
Accrued expenses and other liabilities	1,000,727	311,044
Total Liabilities	48,233,894	38,362,377
Shareholders’ Equity
Common stock (no par value, authorized 650,000,000 shares; issued 507,896,910 and 423,034,027 shares at June 30, 2022 and December 31, 2021)	178,185	148,482
Surplus	4,965,488	3,883,035
Retained earnings	982,146	883,645
Accumulated other comprehensive loss	(108,337)	(17,932)
Treasury stock, at cost (1,568,384 common shares at June 30, 2022 and 1,596,959 common shares at December 31, 2021)	(22,260)	(22,855)
Total Shareholders’ Equity	6,204,913	5,084,066
Total Liabilities and Shareholders’ Equity	54,438,807	43,446,443
Series A
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	111,590	111,590
Series B
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	$ 98,101	$ 98,101